Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of cert...
Ozempic and other GLP-1 RAs could slow progression of some cancers, data suggest
Real-world data show that GLP-1 receptor agonists (GLP-1s) may reduce metastatic progression of certain obesity-related cancers, namely lung, breast,...
Author: Medical Xpress
Read Original Article